In 2024, Emeritus Professor Michael Pender was made a Member of the Order of Australia for significant service to medicine, particularly neurology and MS research, and to tertiary education.
Analysis of data on sleep quality and the presence of comorbidities (having one or more other medical conditions) in people with MS revealed that a wide range of comorbidities negatively impact sleep quality, and having a higher total number of comorbidities is associated with poorer sleep quality.
NAA Chair, Rohan Greenland highlights the neglect of neurological conditions as a disease group and outlines 6 calls to action the NAA is advocating for to ensure neurological conditions receive the recognition, attention and resources they deserve.
In his speech at the National Summit on Neurological Conditions, MS Australia CEO and NAA Chair calls for greater action to support people living with neurological conditions.
A new study has explored low intensity rTMS as a treatment for MS, revealing high compliance and laying the groundwork for future breakthroughs.
For over 30 years, travel agent Lois Marshall has helped people explore new horizons. But her particular journey extends beyond travel — it’s about making a difference for people with multiple sclerosis.
Australian researchers have identified a brain region that enlarges over time in people with relapsing-remitting MS and correlates with the expansion of chronic lesions and nerve damage.
Australian researchers have found a link between COVID-19-related hardships and reduced quality of life.
LEEP member Kate shares her story of MS diagnosis for MS Australia’s World MS Day 2024 advocacy. The 2024-2025 theme ‘My MS Diagnosis’, advocates for timely and accurate identification of MS.
